1. Home
  2. GUG vs BVS Comparison

GUG vs BVS Comparison

Compare GUG & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GUG
  • BVS
  • Stock Information
  • Founded
  • GUG 2021
  • BVS 2011
  • Country
  • GUG United States
  • BVS United States
  • Employees
  • GUG N/A
  • BVS N/A
  • Industry
  • GUG Trusts Except Educational Religious and Charitable
  • BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • GUG Finance
  • BVS Health Care
  • Exchange
  • GUG Nasdaq
  • BVS Nasdaq
  • Market Cap
  • GUG 470.0M
  • BVS 496.7M
  • IPO Year
  • GUG N/A
  • BVS 2021
  • Fundamental
  • Price
  • GUG $15.63
  • BVS $6.85
  • Analyst Decision
  • GUG
  • BVS Strong Buy
  • Analyst Count
  • GUG 0
  • BVS 4
  • Target Price
  • GUG N/A
  • BVS $15.00
  • AVG Volume (30 Days)
  • GUG 108.9K
  • BVS 427.4K
  • Earning Date
  • GUG 01-01-0001
  • BVS 08-05-2025
  • Dividend Yield
  • GUG 9.67%
  • BVS N/A
  • EPS Growth
  • GUG N/A
  • BVS N/A
  • EPS
  • GUG N/A
  • BVS N/A
  • Revenue
  • GUG N/A
  • BVS $567,699,000.00
  • Revenue This Year
  • GUG N/A
  • BVS N/A
  • Revenue Next Year
  • GUG N/A
  • BVS $6.11
  • P/E Ratio
  • GUG N/A
  • BVS N/A
  • Revenue Growth
  • GUG N/A
  • BVS 8.60
  • 52 Week Low
  • GUG $12.71
  • BVS $5.62
  • 52 Week High
  • GUG $15.06
  • BVS $14.38
  • Technical
  • Relative Strength Index (RSI)
  • GUG 62.89
  • BVS 53.47
  • Support Level
  • GUG $15.56
  • BVS $6.52
  • Resistance Level
  • GUG $15.92
  • BVS $7.21
  • Average True Range (ATR)
  • GUG 0.22
  • BVS 0.28
  • MACD
  • GUG 0.03
  • BVS 0.06
  • Stochastic Oscillator
  • GUG 66.85
  • BVS 63.64

About GUG Guggenheim Active Allocation Fund of Beneficial Interest

Guggenheim Active Allocation Fund is a diversified closed-end management investment company. The fund's investment objective is to maximize total return through a combination of current income and capital appreciation. The company invests in both fixed-income and other debt instruments selected from a variety of sectors and credit qualities, and may also invest in equities. It uses tactical asset allocation models to determine the optimal allocation of its assets between fixed-income and equity securities. A majority of its investments are made in corporate bonds and the rest in senior floating rate interests, asset-backed securities, preferred stocks, and other securities.

About BVS Bioventus Inc.

Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

Share on Social Networks: